| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Nang Kuang Pharmaceutical Co. Ltd (TWO: 1752)
1752 Technical Analysis
3
| As on 18th Jan 2022 1752 STOCK Price closed @ 39.55 and we RECOMMEND Buy for LONG-TERM with Stoploss of 38.88 & Buy for SHORT-TERM with Stoploss of 39.52 we also expect STOCK to react on Following IMPORTANT LEVELS. |
1752STOCK Price
| Open | 39.50 | Change | Price | % |
| High | 39.65 | 1 Day | 0.10 | 0.25 |
| Low | 39.20 | 1 Week | 2.35 | 6.32 |
| Close | 39.55 | 1 Month | 3.55 | 9.86 |
| Volume | 353504 | 1 Year | -0.95 | -2.35 |
| 52 Week High 42.50 | 52 Week Low 0.17 | ||||
TWO Taiwan Most Active Stocks
| 1815 | 24.85 | 9.96% |
| 5309 | 43.70 | 9.94% |
| 1569 | 56.30 | 3.68% |
| 3511 | 48.65 | 9.94% |
| 6274 | 167.00 | 7.74% |
| 3323 | 35.35 | 9.95% |
| 8032 | 82.50 | 1.85% |
| 5347 | 91.70 | 2.00% |
| 3081 | 368.50 | 2.93% |
| 4931 | 52.40 | 8.15% |
TWO Taiwan Top Gainers Stocks
TWO Taiwan Top Losers Stocks
| 1752 Daily Charts |
1752 Intraday Charts |
Whats New @ Bazaartrend |
1752 Free Analysis |
|
|
1752 Important Levels Intraday
| RESISTANCE | 40.42 |
| RESISTANCE | 40.14 |
| RESISTANCE | 39.97 |
| RESISTANCE | 39.80 |
| SUPPORT | 39.30 |
| SUPPORT | 39.13 |
| SUPPORT | 38.96 |
| SUPPORT | 38.68 |
1752 Forecast November 2024
| 4th UP Forecast | 43.98 |
| 3rd UP Forecast | 42.56 |
| 2nd UP Forecast | 41.68 |
| 1st UP Forecast | 40.8 |
| 1st DOWN Forecast | 38.3 |
| 2nd DOWN Forecast | 37.42 |
| 3rd DOWN Forecast | 36.54 |
| 4th DOWN Forecast | 35.12 |
1752 Weekly Forecast
| 4th UP Forecast | 41.86 |
| 3rd UP Forecast | 41.12 |
| 2nd UP Forecast | 40.66 |
| 1st UP Forecast | 40.20 |
| 1st DOWN Forecast | 38.90 |
| 2nd DOWN Forecast | 38.44 |
| 3rd DOWN Forecast | 37.98 |
| 4th DOWN Forecast | 37.24 |
1752 Forecast2024
| 4th UP Forecast | 121.7 |
| 3rd UP Forecast | 95.35 |
| 2nd UP Forecast | 79.07 |
| 1st UP Forecast | 62.78 |
| 1st DOWN Forecast | 16.32 |
| 2nd DOWN Forecast | 0.03 |
| 3rd DOWN Forecast | -16.25 |
| 4th DOWN Forecast | -42.6 |
Nang Kuang Pharmaceutical Co. Ltd ( TWO Taiwan Symbol : 1752 )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
1752 Business Profile
Nang Kuang Pharmaceutical Co., Ltd. operates as a pharmaceutical company primarily in Taiwan. The company provides parenterals, aseptic parenterals, lyophilized injections, pre-filled syringes, and pre-mixed IV infusion bags, as well as tablets, capsules, topical products, and oral suspensions. It offers various products in the areas of cardiovascular system, gastrointestinal system, nervous system, alimentary and metabolism, blood, antineoplastic and immunomodulatory, musculo-skeletal system, respiratory system, dermatological, genito-urinary and sex hormone, systemic hormone, systemic antibacterial, and cosmetics, as well as hospital solution. Nang Kuang Pharmaceutical Co., Ltd. was founded in 1963 and is headquartered in Tainan City, Taiwan. Address: No. 1001, Zhongshan Road, Tainan City, Taiwan, 71243
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service